全文获取类型
收费全文 | 5495篇 |
免费 | 803篇 |
国内免费 | 899篇 |
出版年
2024年 | 51篇 |
2023年 | 296篇 |
2022年 | 424篇 |
2021年 | 602篇 |
2020年 | 496篇 |
2019年 | 562篇 |
2018年 | 443篇 |
2017年 | 363篇 |
2016年 | 349篇 |
2015年 | 419篇 |
2014年 | 548篇 |
2013年 | 439篇 |
2012年 | 267篇 |
2011年 | 223篇 |
2010年 | 122篇 |
2009年 | 119篇 |
2008年 | 96篇 |
2007年 | 96篇 |
2006年 | 101篇 |
2005年 | 106篇 |
2004年 | 90篇 |
2003年 | 108篇 |
2002年 | 78篇 |
2001年 | 80篇 |
2000年 | 89篇 |
1999年 | 64篇 |
1998年 | 50篇 |
1997年 | 60篇 |
1996年 | 55篇 |
1995年 | 59篇 |
1994年 | 49篇 |
1993年 | 23篇 |
1992年 | 46篇 |
1991年 | 26篇 |
1990年 | 18篇 |
1989年 | 24篇 |
1988年 | 20篇 |
1987年 | 17篇 |
1986年 | 10篇 |
1985年 | 23篇 |
1984年 | 30篇 |
1983年 | 17篇 |
1982年 | 22篇 |
1981年 | 7篇 |
1980年 | 4篇 |
1979年 | 2篇 |
1978年 | 3篇 |
1977年 | 1篇 |
排序方式: 共有7197条查询结果,搜索用时 739 毫秒
111.
Anti-cancer activity of tolfenamic acid (TA) in preclinical models for pancreatic cancer (PaCa) is well established. Since the dosage for anti-cancer actions of TA is rather high, we recently demonstrated that IC50 values of Copper-TA are 30–80% less than TA in 12 cancer cell lines. This study elucidates the underlying mechanisms of Copper-TA in PaCa cells. Control and Copper-TA (IC50) treated PaCa cells were processed by next-generation sequencing (NGS) to determine differentially expressed genes using HTG EdgeSeq Oncology Biomarker panel. Ingenuity Pathway Analysis (IPA®) was used to identify functional significance of altered genes. The conformational studies for assessing the expression of key regulators and genes were conducted by Western blot and qPCR. IPA® identified several networks, regulators, as well as molecular and cellular functions associated with cancer. The top 5 molecular and cellular functions affected by Cu-TA treatment were cell death and survival, cellular development, cell growth and proliferation, cell cycle and cellular movement. The expression of top upstream regulators was confirmed by Western blot analysis while qPCR results of selected genes demonstrated that Copper-TA is efficacious at lower doses than TA. Results suggest that Copper-TA alters genes/key regulators associated with cancer and potentially serve as an effective anti-cancer agent. 相似文献
112.
113.
114.
Vemanna S. Ramu Akashata Dawane Seonghee Lee Sunhee Oh Hee-Kyung Lee Liang Sun Muthappa Senthil-Kumar Kirankumar S. Mysore 《Molecular Plant Pathology》2020,21(11):1481-1494
Ribosomes play an integral part in plant growth, development, and defence responses. We report here the role of ribosomal protein large (RPL) subunit QM/RPL10 in nonhost disease resistance. The RPL10-silenced Nicotiana benthamiana plants showed compromised disease resistance against nonhost pathogen Pseudomonas syringae pv. tomato T1. The RNA-sequencing analysis revealed that many genes involved in defence and protein translation mechanisms were differentially affected due to silencing of NbRPL10. Arabidopsis AtRPL10 RNAi and rpl10 mutant lines showed compromised nonhost disease resistance to P. syringae pv. tomato T1 and P. syringae pv. tabaci. Overexpression of AtRPL10A in Arabidopsis resulted in reduced susceptibility against host pathogen P. syringae pv. tomato DC3000. RPL10 interacts with the RNA recognition motif protein and ribosomal proteins RPL30, RPL23, and RPS30 in the yeast two-hybrid assay. Silencing or mutants of genes encoding these RPL10-interacting proteins in N. benthamiana or Arabidopsis, respectively, also showed compromised disease resistance to nonhost pathogens. These results suggest that QM/RPL10 positively regulates the defence and translation-associated genes during nonhost pathogen infection. 相似文献
115.
116.
Yingfan Cai Xiaoyan Cai Qinglian Wang Ping Wang Yu Zhang Chaowei Cai Yanchao Xu Kunbo Wang Zhongli Zhou Chenxiao Wang Shuaipeng Geng Bo Li Qi Dong Yuqing Hou Heng Wang Peng Ai Zhen Liu Feifei Yi Minshan Sun Guoyong An Jieru Cheng Yuanyuan Zhang Qian Shi Yuanhui Xie Xinying Shi Ying Chang Feifei Huang Yun Chen Shimiao Hong Lingyu Mi Quan Sun Lin Zhang Baoliang Zhou Renhai Peng Xiao Zhang Fang Liu 《Plant biotechnology journal》2020,18(3):814-828
117.
118.
Genome assembly provides insights into the genome evolution and flowering regulation of orchardgrass
119.
Jason D. Roh Nicholas Houstis Andy Yu Bliss Chang Ashish Yeri Haobo Li Ryan Hobson Carolin Lerchenmüller Ana Vujic Vinita Chaudhari Federico Damilano Colin Platt Daniel Zlotoff Richard T. Lee Ravi Shah Michael Jerosch‐Herold Anthony Rosenzweig 《Aging cell》2020,19(6)
Heart failure with preserved ejection fraction (HFpEF) is the most common type of HF in older adults. Although no pharmacological therapy has yet improved survival in HFpEF, exercise training (ExT) has emerged as the most effective intervention to improving functional outcomes in this age‐related disease. The molecular mechanisms by which ExT induces its beneficial effects in HFpEF, however, remain largely unknown. Given the strong association between aging and HFpEF, we hypothesized that ExT might reverse cardiac aging phenotypes that contribute to HFpEF pathophysiology and additionally provide a platform for novel mechanistic and therapeutic discovery. Here, we show that aged (24–30 months) C57BL/6 male mice recapitulate many of the hallmark features of HFpEF, including preserved left ventricular ejection fraction, subclinical systolic dysfunction, diastolic dysfunction, impaired cardiac reserves, exercise intolerance, and pathologic cardiac hypertrophy. Similar to older humans, ExT in old mice improved exercise capacity, diastolic function, and contractile reserves, while reducing pulmonary congestion. Interestingly, RNAseq of explanted hearts showed that ExT did not significantly modulate biological pathways targeted by conventional HF medications. However, it reversed multiple age‐related pathways, including the global downregulation of cell cycle pathways seen in aged hearts, which was associated with increased capillary density, but no effects on cardiac mass or fibrosis. Taken together, these data demonstrate that the aged C57BL/6 male mouse is a valuable model for studying the role of aging biology in HFpEF pathophysiology, and provide a molecular framework for how ExT potentially reverses cardiac aging phenotypes in HFpEF. 相似文献
120.